Description:

ODM derived from http://clinicaltrials.gov/show/NCT00245765

Link:

http://clinicaltrials.gov/show/NCT00245765

Keywords:
Versions (1) ▾
  1. 12/11/13
Uploaded on:

December 11, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00245765 Chronic Plaque Psoriasis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
men and women > 18 years
Chronic plaque psoriasis stable for at least 3 months and moderate to severe for at least 6 months
PASI ≥ 12 and BSA ≥ 10%
Candidates for systemic psoriasis therapy and/or phototherapy and/or photochemotherapy
Exclusion Criteria
Erythrodermic, guttate, palmar or plantar, generalized pustular form of psoriasis
A history of chronic infection, recent serious or life-threatening infection (within six months, including herpes zoster), or any current sign or symptom that may indicate an infection (e.g. fever, cough)
Leukocyte Count, White Blood Cell Count procedure (WBC)
Suspected or diagnosed demyelinating disease of the central nervous system (e.g. multiple sclerosis or optic neuritis)
Lupus Erythematosus, Systemic
Non respect of adequate wash out periods for treatments that might have an impact on the disease
Any associated disease that could be impacted by the study treatment intake
Any other condition, which in the Investigator's judgment would make the subject unsuitable for inclusion in the study